UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:CYP51A1-KRIT1 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: CYP51A1-KRIT1 | FusionPDB ID: 21113 | FusionGDB2.0 ID: 21113 | Hgene | Tgene | Gene symbol | CYP51A1 | KRIT1 | Gene ID | 1595 | 889 |
Gene name | cytochrome P450 family 51 subfamily A member 1 | KRIT1 ankyrin repeat containing | |
Synonyms | CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1 | CAM|CCM1 | |
Cytomap | 7q21.2 | 7q21.2 | |
Type of gene | protein-coding | protein-coding | |
Description | lanosterol 14-alpha demethylaseCYPLIcytochrome P450 51A1cytochrome P450, 51 (lanosterol 14-alpha-demethylase)cytochrome P450, family 51, subfamily A, polypeptide 1cytochrome P450-14DMcytochrome P45014DMcytochrome P450LIsterol 14-alpha demethylase | krev interaction trapped protein 1ankyrin repeat-containing protein Krit1cerebral cavernous malformations 1 proteinkrev interaction trapped 1 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q16850 | O00522 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000003100, ENST00000450723, | ENST00000466166, ENST00000340022, ENST00000394503, ENST00000394505, ENST00000394507, ENST00000412043, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 4 X 5 X 4=80 | 3 X 3 X 3=27 |
# samples | 4 | 3 | |
** MAII score | log2(4/80*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: CYP51A1 [Title/Abstract] AND KRIT1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | CYP51A1(91755566)-KRIT1(91864960), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | CYP51A1-KRIT1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CYP51A1-KRIT1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CYP51A1-KRIT1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CYP51A1-KRIT1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CYP51A1-KRIT1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. CYP51A1-KRIT1 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. CYP51A1-KRIT1 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CYP51A1 | GO:0006694 | steroid biosynthetic process | 20149798 |
Fusion gene breakpoints across CYP51A1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across KRIT1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | Non-Cancer | 5357N | CYP51A1 | chr7 | 91755566 | - | KRIT1 | chr7 | 91864960 | - |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000003100 | CYP51A1 | chr7 | 91755566 | - | ENST00000394507 | KRIT1 | chr7 | 91864960 | - | 4429 | 936 | 166 | 2661 | 831 |
ENST00000003100 | CYP51A1 | chr7 | 91755566 | - | ENST00000340022 | KRIT1 | chr7 | 91864960 | - | 3985 | 936 | 166 | 2661 | 831 |
ENST00000003100 | CYP51A1 | chr7 | 91755566 | - | ENST00000412043 | KRIT1 | chr7 | 91864960 | - | 3040 | 936 | 166 | 2661 | 831 |
ENST00000003100 | CYP51A1 | chr7 | 91755566 | - | ENST00000394505 | KRIT1 | chr7 | 91864960 | - | 3040 | 936 | 166 | 2661 | 831 |
ENST00000003100 | CYP51A1 | chr7 | 91755566 | - | ENST00000394503 | KRIT1 | chr7 | 91864960 | - | 2881 | 936 | 166 | 2517 | 783 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000003100 | ENST00000394507 | CYP51A1 | chr7 | 91755566 | - | KRIT1 | chr7 | 91864960 | - | 0.000120029 | 0.99987996 |
ENST00000003100 | ENST00000340022 | CYP51A1 | chr7 | 91755566 | - | KRIT1 | chr7 | 91864960 | - | 0.000136473 | 0.9998635 |
ENST00000003100 | ENST00000412043 | CYP51A1 | chr7 | 91755566 | - | KRIT1 | chr7 | 91864960 | - | 0.000311928 | 0.99968815 |
ENST00000003100 | ENST00000394505 | CYP51A1 | chr7 | 91755566 | - | KRIT1 | chr7 | 91864960 | - | 0.000311928 | 0.99968815 |
ENST00000003100 | ENST00000394503 | CYP51A1 | chr7 | 91755566 | - | KRIT1 | chr7 | 91864960 | - | 0.000352204 | 0.99964774 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >21113_21113_1_CYP51A1-KRIT1_CYP51A1_chr7_91755566_ENST00000003100_KRIT1_chr7_91864960_ENST00000340022_length(amino acids)=831AA_BP=256 MAAAAGMLLLGLLQAGGSVLGQAMEKVTGGNLLSMLLIACAFTLSLVYLIRLAAGHLVQLPAGVKSPPYIFSPIPFLGHAIAFGKSPIEF LENAYEKYGPVFSFTMVGKTFTYLLGSDAAALLFNSKNEDLNAEDVYSRLTTPVFGKGVAYDVPNPVFLEQKKMLKSGLNIAHFKQHVSI IEKETKEYFESWGESGEKNVFEALSELIILTASHCLHGKEIRSQLNEKVAQLYADLDGGFSHAAWLLPGWLPLPSFRWLDERHAQSHFIP ALFRPSPLERIKTNVINPAYATESGQTENSLHMGYSALEIKSKMLALEKADTCIYNPLFGSDLQYTNRVDKVVINPYFGLGAPDYSKIQI PKQEKWQRSMSSVTEDKERQWVDDFPLHRSACEGDSELLSRLLSERFSVNQLDSDHWAPIHYACWYGKVEATRILLEKGKCNPNLLNGQL SSPLHFAAGGGHAEIVQILLNHPETDRHITDQQGRSPLNICEENKQNNWEEAAKLLKEAINKPYEKVRIYRMDGSYRSVELKHGNNTTVQ QIMEGMRLSQETQQYFTIWICSENLSLQLKPYHKPLQHVRDWPEILAELTNLDPQRETPQLFLRRDVRLPLEVEKQIEDPLAILILFDEA RYNLLKGFYTAPDAKLITLASLLLQIVYGNYESKKHKQGFLNEENLKSIVPVTKLKSKAPHWTNRILHEYKNLSTSEGVSKEMHHLQRMF LQNCWEIPTYGAAFFTGQIFTKASPSNHKVIPVYVGVNIKGLHLLNMETKALLISLKYGCFMWQLGDTDTCFQIHSMENKMSFIVHTKQA -------------------------------------------------------------- >21113_21113_2_CYP51A1-KRIT1_CYP51A1_chr7_91755566_ENST00000003100_KRIT1_chr7_91864960_ENST00000394503_length(amino acids)=783AA_BP=256 MAAAAGMLLLGLLQAGGSVLGQAMEKVTGGNLLSMLLIACAFTLSLVYLIRLAAGHLVQLPAGVKSPPYIFSPIPFLGHAIAFGKSPIEF LENAYEKYGPVFSFTMVGKTFTYLLGSDAAALLFNSKNEDLNAEDVYSRLTTPVFGKGVAYDVPNPVFLEQKKMLKSGLNIAHFKQHVSI IEKETKEYFESWGESGEKNVFEALSELIILTASHCLHGKEIRSQLNEKVAQLYADLDGGFSHAAWLLPGWLPLPSFRWLDERHAQSHFIP ALFRPSPLERIKTNVINPAYATESGQTENSLHMGYSALEIKSKMLALEKADTCIYNPLFGSDLQYTNRVDKVVINPYFGLGAPDYSKIQI PKQEKWQRSMSSVTEDKYGKVEATRILLEKGKCNPNLLNGQLSSPLHFAAGGGHAEIVQILLNHPETDRHITDQQGRSPLNICEENKQNN WEEAAKLLKEAINKPYEKVRIYRMDGSYRSVELKHGNNTTVQQIMEGMRLSQETQQYFTIWICSENLSLQLKPYHKPLQHVRDWPEILAE LTNLDPQRETPQLFLRRDVRLPLEVEKQIEDPLAILILFDEARYNLLKGFYTAPDAKLITLASLLLQIVYGNYESKKHKQGFLNEENLKS IVPVTKLKSKAPHWTNRILHEYKNLSTSEGVSKEMHHLQRMFLQNCWEIPTYGAAFFTGQIFTKASPSNHKVIPVYVGVNIKGLHLLNME -------------------------------------------------------------- >21113_21113_3_CYP51A1-KRIT1_CYP51A1_chr7_91755566_ENST00000003100_KRIT1_chr7_91864960_ENST00000394505_length(amino acids)=831AA_BP=256 MAAAAGMLLLGLLQAGGSVLGQAMEKVTGGNLLSMLLIACAFTLSLVYLIRLAAGHLVQLPAGVKSPPYIFSPIPFLGHAIAFGKSPIEF LENAYEKYGPVFSFTMVGKTFTYLLGSDAAALLFNSKNEDLNAEDVYSRLTTPVFGKGVAYDVPNPVFLEQKKMLKSGLNIAHFKQHVSI IEKETKEYFESWGESGEKNVFEALSELIILTASHCLHGKEIRSQLNEKVAQLYADLDGGFSHAAWLLPGWLPLPSFRWLDERHAQSHFIP ALFRPSPLERIKTNVINPAYATESGQTENSLHMGYSALEIKSKMLALEKADTCIYNPLFGSDLQYTNRVDKVVINPYFGLGAPDYSKIQI PKQEKWQRSMSSVTEDKERQWVDDFPLHRSACEGDSELLSRLLSERFSVNQLDSDHWAPIHYACWYGKVEATRILLEKGKCNPNLLNGQL SSPLHFAAGGGHAEIVQILLNHPETDRHITDQQGRSPLNICEENKQNNWEEAAKLLKEAINKPYEKVRIYRMDGSYRSVELKHGNNTTVQ QIMEGMRLSQETQQYFTIWICSENLSLQLKPYHKPLQHVRDWPEILAELTNLDPQRETPQLFLRRDVRLPLEVEKQIEDPLAILILFDEA RYNLLKGFYTAPDAKLITLASLLLQIVYGNYESKKHKQGFLNEENLKSIVPVTKLKSKAPHWTNRILHEYKNLSTSEGVSKEMHHLQRMF LQNCWEIPTYGAAFFTGQIFTKASPSNHKVIPVYVGVNIKGLHLLNMETKALLISLKYGCFMWQLGDTDTCFQIHSMENKMSFIVHTKQA -------------------------------------------------------------- >21113_21113_4_CYP51A1-KRIT1_CYP51A1_chr7_91755566_ENST00000003100_KRIT1_chr7_91864960_ENST00000394507_length(amino acids)=831AA_BP=256 MAAAAGMLLLGLLQAGGSVLGQAMEKVTGGNLLSMLLIACAFTLSLVYLIRLAAGHLVQLPAGVKSPPYIFSPIPFLGHAIAFGKSPIEF LENAYEKYGPVFSFTMVGKTFTYLLGSDAAALLFNSKNEDLNAEDVYSRLTTPVFGKGVAYDVPNPVFLEQKKMLKSGLNIAHFKQHVSI IEKETKEYFESWGESGEKNVFEALSELIILTASHCLHGKEIRSQLNEKVAQLYADLDGGFSHAAWLLPGWLPLPSFRWLDERHAQSHFIP ALFRPSPLERIKTNVINPAYATESGQTENSLHMGYSALEIKSKMLALEKADTCIYNPLFGSDLQYTNRVDKVVINPYFGLGAPDYSKIQI PKQEKWQRSMSSVTEDKERQWVDDFPLHRSACEGDSELLSRLLSERFSVNQLDSDHWAPIHYACWYGKVEATRILLEKGKCNPNLLNGQL SSPLHFAAGGGHAEIVQILLNHPETDRHITDQQGRSPLNICEENKQNNWEEAAKLLKEAINKPYEKVRIYRMDGSYRSVELKHGNNTTVQ QIMEGMRLSQETQQYFTIWICSENLSLQLKPYHKPLQHVRDWPEILAELTNLDPQRETPQLFLRRDVRLPLEVEKQIEDPLAILILFDEA RYNLLKGFYTAPDAKLITLASLLLQIVYGNYESKKHKQGFLNEENLKSIVPVTKLKSKAPHWTNRILHEYKNLSTSEGVSKEMHHLQRMF LQNCWEIPTYGAAFFTGQIFTKASPSNHKVIPVYVGVNIKGLHLLNMETKALLISLKYGCFMWQLGDTDTCFQIHSMENKMSFIVHTKQA -------------------------------------------------------------- >21113_21113_5_CYP51A1-KRIT1_CYP51A1_chr7_91755566_ENST00000003100_KRIT1_chr7_91864960_ENST00000412043_length(amino acids)=831AA_BP=256 MAAAAGMLLLGLLQAGGSVLGQAMEKVTGGNLLSMLLIACAFTLSLVYLIRLAAGHLVQLPAGVKSPPYIFSPIPFLGHAIAFGKSPIEF LENAYEKYGPVFSFTMVGKTFTYLLGSDAAALLFNSKNEDLNAEDVYSRLTTPVFGKGVAYDVPNPVFLEQKKMLKSGLNIAHFKQHVSI IEKETKEYFESWGESGEKNVFEALSELIILTASHCLHGKEIRSQLNEKVAQLYADLDGGFSHAAWLLPGWLPLPSFRWLDERHAQSHFIP ALFRPSPLERIKTNVINPAYATESGQTENSLHMGYSALEIKSKMLALEKADTCIYNPLFGSDLQYTNRVDKVVINPYFGLGAPDYSKIQI PKQEKWQRSMSSVTEDKERQWVDDFPLHRSACEGDSELLSRLLSERFSVNQLDSDHWAPIHYACWYGKVEATRILLEKGKCNPNLLNGQL SSPLHFAAGGGHAEIVQILLNHPETDRHITDQQGRSPLNICEENKQNNWEEAAKLLKEAINKPYEKVRIYRMDGSYRSVELKHGNNTTVQ QIMEGMRLSQETQQYFTIWICSENLSLQLKPYHKPLQHVRDWPEILAELTNLDPQRETPQLFLRRDVRLPLEVEKQIEDPLAILILFDEA RYNLLKGFYTAPDAKLITLASLLLQIVYGNYESKKHKQGFLNEENLKSIVPVTKLKSKAPHWTNRILHEYKNLSTSEGVSKEMHHLQRMF LQNCWEIPTYGAAFFTGQIFTKASPSNHKVIPVYVGVNIKGLHLLNMETKALLISLKYGCFMWQLGDTDTCFQIHSMENKMSFIVHTKQA -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr7:91755566/chr7:91864960) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CYP51A1 | KRIT1 |
FUNCTION: A cytochrome P450 monooxygenase involved in sterol biosynthesis. Catalyzes 14-alpha demethylation of lanosterol and 24,25-dihydrolanosterol likely through sequential oxidative conversion of 14-alpha methyl group to hydroxymethyl, then to carboxylaldehyde, followed by the formation of the delta 14,15 double bond in the sterol core and concomitant release of formic acid (PubMed:20149798, PubMed:8619637). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) (PubMed:20149798, PubMed:8619637). {ECO:0000269|PubMed:20149798, ECO:0000269|PubMed:8619637}. | FUNCTION: Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity (By similarity). Negative regulator of angiogenesis. Inhibits endothelial proliferation, apoptosis, migration, lumen formation and sprouting angiogenesis in primary endothelial cells. Promotes AKT phosphorylation in a NOTCH-dependent and independent manner, and inhibits ERK1/2 phosphorylation indirectly through activation of the DELTA-NOTCH cascade. Acts in concert with CDH5 to establish and maintain correct endothelial cell polarity and vascular lumen and these effects are mediated by recruitment and activation of the Par polarity complex and RAP1B. Required for the localization of phosphorylated PRKCZ, PARD3, TIAM1 and RAP1B to the cell junction, and cell junction stabilization. Plays a role in integrin signaling via its interaction with ITGB1BP1; this prevents the interaction between ITGB1 and ITGB1BP1. Microtubule-associated protein that binds to phosphatidylinositol 4,5-bisphosphate (PIP2)-containing membranes in a GTP-bound RAP1-dependent manner. Plays an important role in the maintenance of the intracellular reactive oxygen species (ROS) homeostasis to prevent oxidative cellular damage. Regulates the homeostasis of intracellular ROS through an antioxidant pathway involving FOXO1 and SOD2. Facilitates the down-regulation of cyclin-D1 (CCND1) levels required for cell transition from proliferative growth to quiescence by preventing the accumulation of intracellular ROS through the modulation of FOXO1 and SOD2 levels. {ECO:0000250|UniProtKB:Q6S5J6, ECO:0000269|PubMed:11741838, ECO:0000269|PubMed:17916086, ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:20616044, ECO:0000269|PubMed:20668652, ECO:0000269|PubMed:21633110, ECO:0000269|PubMed:23317506}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CYP51A1 | chr7:91755566 | chr7:91864960 | ENST00000003100 | - | 5 | 10 | 24_44 | 256.6666666666667 | 510.0 | Transmembrane | Helical |
Hgene | CYP51A1 | chr7:91755566 | chr7:91864960 | ENST00000450723 | - | 5 | 10 | 24_44 | 151.66666666666666 | 405.0 | Transmembrane | Helical |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000340022 | 6 | 19 | 420_734 | 161.66666666666666 | 737.0 | Domain | FERM | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394503 | 5 | 17 | 420_734 | 161.66666666666666 | 689.0 | Domain | FERM | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394505 | 6 | 19 | 420_734 | 161.66666666666666 | 737.0 | Domain | FERM | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394507 | 7 | 20 | 420_734 | 161.66666666666666 | 737.0 | Domain | FERM | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000412043 | 6 | 19 | 420_734 | 161.66666666666666 | 737.0 | Domain | FERM | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000340022 | 6 | 19 | 287_316 | 161.66666666666666 | 737.0 | Repeat | ANK 1 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000340022 | 6 | 19 | 320_350 | 161.66666666666666 | 737.0 | Repeat | ANK 2 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000340022 | 6 | 19 | 354_383 | 161.66666666666666 | 737.0 | Repeat | ANK 3 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000340022 | 6 | 19 | 388_419 | 161.66666666666666 | 737.0 | Repeat | ANK 4 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394503 | 5 | 17 | 287_316 | 161.66666666666666 | 689.0 | Repeat | ANK 1 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394503 | 5 | 17 | 320_350 | 161.66666666666666 | 689.0 | Repeat | ANK 2 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394503 | 5 | 17 | 354_383 | 161.66666666666666 | 689.0 | Repeat | ANK 3 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394503 | 5 | 17 | 388_419 | 161.66666666666666 | 689.0 | Repeat | ANK 4 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394505 | 6 | 19 | 287_316 | 161.66666666666666 | 737.0 | Repeat | ANK 1 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394505 | 6 | 19 | 320_350 | 161.66666666666666 | 737.0 | Repeat | ANK 2 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394505 | 6 | 19 | 354_383 | 161.66666666666666 | 737.0 | Repeat | ANK 3 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394505 | 6 | 19 | 388_419 | 161.66666666666666 | 737.0 | Repeat | ANK 4 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394507 | 7 | 20 | 287_316 | 161.66666666666666 | 737.0 | Repeat | ANK 1 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394507 | 7 | 20 | 320_350 | 161.66666666666666 | 737.0 | Repeat | ANK 2 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394507 | 7 | 20 | 354_383 | 161.66666666666666 | 737.0 | Repeat | ANK 3 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394507 | 7 | 20 | 388_419 | 161.66666666666666 | 737.0 | Repeat | ANK 4 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000412043 | 6 | 19 | 287_316 | 161.66666666666666 | 737.0 | Repeat | ANK 1 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000412043 | 6 | 19 | 320_350 | 161.66666666666666 | 737.0 | Repeat | ANK 2 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000412043 | 6 | 19 | 354_383 | 161.66666666666666 | 737.0 | Repeat | ANK 3 | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000412043 | 6 | 19 | 388_419 | 161.66666666666666 | 737.0 | Repeat | ANK 4 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000340022 | 6 | 19 | 1_170 | 161.66666666666666 | 737.0 | Region | Note=N-terminal domain similar to Nudix hydrolase domain | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394503 | 5 | 17 | 1_170 | 161.66666666666666 | 689.0 | Region | Note=N-terminal domain similar to Nudix hydrolase domain | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394505 | 6 | 19 | 1_170 | 161.66666666666666 | 737.0 | Region | Note=N-terminal domain similar to Nudix hydrolase domain | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000394507 | 7 | 20 | 1_170 | 161.66666666666666 | 737.0 | Region | Note=N-terminal domain similar to Nudix hydrolase domain | |
Tgene | KRIT1 | chr7:91755566 | chr7:91864960 | ENST00000412043 | 6 | 19 | 1_170 | 161.66666666666666 | 737.0 | Region | Note=N-terminal domain similar to Nudix hydrolase domain |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
CYP51A1 | |
KRIT1 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to CYP51A1-KRIT1 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to CYP51A1-KRIT1 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |